Tag Archive for: CEO

Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix® Spinal System

/in

Experienced MedTech leader to guide Amber Implants’ transition from development into commercialization following  FDA clearance of the VCFix® Spinal System Company preparing for U.S. market launch in 2026 THE HAGUE, The Netherlands, Nov. 6, 2025 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the appointment of Vincent Gardès as Chief Executive […]

Read more

Jacob Falck Hansen appointed as Chief Executive Officer of Vesper Bio

/in

Copenhagen, Denmark, 01 July 2025 – Vesper Bio ApS (“Vesper” or “the Company”), a clinical stage biotech developing an oral therapy for frontotemporal dementia, today announces the appointment of Jacob Falck Hansen as Chief Executive Officer (CEO). Jacob Falck Hansen brings more than 15 years of leadership experience from the pharmaceutical and biotech industry. He […]

Read more

Gergely Sved appointed CEO of Ellab

/in

27 March 2025 Hillerød, Denmark – Ellab, the leading provider of validation, monitoring, and calibration services and solutions, announces that it has appointed Gergely Sved as its new Chief Executive Officer (CEO), following the departure of Ludvig Enlund. Mr Sved will formally join the company in June, with Chief Financial Officer Andreas Morthorst acting as […]

Read more

NeoPhore appoints Michael Shih as Chief Executive Officer

/in

Highly experienced corporate development leader with a track record of international pharma and biotech deal-making New CEO to drive growth strategy to maximise the potential of drug discovery pipeline to treat cancer London UK, 16 December 2024 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the appointment of Michael Shih as Chief Executive […]

Read more

Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025

/in

David Epstein, formerly CEO of Seagen, joins as Chair & Chief Executive Officer Mehdi Shahidi, previously SVP and Chief Medical Officer at Boehringer Ingelheim, joins as Head of Development & Chief Medical Officer James Sabry, ex-Head of Pharma Partnering at Roche, joins the Board as Vice-Chair [28 October 2024]: [London, UK/ Boston, US]: Ottimo Pharma, […]

Read more